NCI Cancer Bulletin for November 29, 2011

November 29, 2011 • Volume 8 / Number 23 Read the NCI Cancer Bulletin The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer. News Read This Issue Featured Article: Researchers Uncover New Mechanism of Resistance to Melanoma Drug » Survey of Oncologists Suggests Lack of Progress in Cancer Pain Management » Trial Confirms Efficacy of HPV Vaccine, Shows Cross-Protection » Genetic Study Yields Clues to Neuroendocrine Prostate Cancer » Commentary Read This Issue A Conversation with Dr. Mason Bond on Improving the Treatment of Patients with Ewing Sarcoma » In Depth Read This Issue Study Raises Concerns about Using Cancer Cell Lines to Test Drug Resistance » Unexpected Complications: Treating Cancer during Pregnancy » Interpreting Risk: Direct-to-Consumer Genetic Testing » Featured Clinical Trial: Novel Combination Chemotherapy for Localized Ewing Sarcoma » Updates Read This Issue FDA Update » Notes » Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov.